Academic Journal
Role of β-adrenergic signaling in masseter muscle.
Title: | Role of β-adrenergic signaling in masseter muscle. |
---|---|
Authors: | Aiko Ito, Yoshiki Ohnuki, Kenji Suita, Misao Ishikawa, Yasumasa Mototani, Kouichi Shiozawa, Naoya Kawamura, Yuka Yagisawa, Megumi Nariyama, Daisuke Umeki, Yoshiki Nakamura, Satoshi Okumura |
Source: | PLoS ONE, Vol 14, Iss 4, p e0215539 (2019) |
Publisher Information: | Public Library of Science (PLoS), 2019. |
Publication Year: | 2019 |
Collection: | LCC:Medicine LCC:Science |
Subject Terms: | Medicine, Science |
More Details: | In skeletal muscle, the major isoform of β-adrenergic receptor (β-AR) is β2-AR and the minor isoform is β1-AR, which is opposite to the situation in cardiac muscle. Despite extensive studies in cardiac muscle, the physiological roles of the β-AR subtypes in skeletal muscle are not fully understood. Therefore, in this work, we compared the effects of chronic β1- or β2-AR activation with a specific β1-AR agonist, dobutamine (DOB), or a specific β2-AR agonist, clenbuterol (CB), on masseter and cardiac muscles in mice. In cardiac muscle, chronic β1-AR stimulation induced cardiac hypertrophy, fibrosis and myocyte apoptosis, whereas chronic β2-AR stimulation induced cardiac hypertrophy without histological abnormalities. In masseter muscle, however, chronic β1-AR stimulation did not induce muscle hypertrophy, but did induce fibrosis and apoptosis concomitantly with increased levels of p44/42 MAPK (ERK1/2) (Thr-202/Tyr-204), calmodulin kinase II (Thr-286) and mammalian target of rapamycin (mTOR) (Ser-2481) phosphorylation. On the other hand, chronic β2-AR stimulation in masseter muscle induced muscle hypertrophy without histological abnormalities, as in the case of cardiac muscle, concomitantly with phosphorylation of Akt (Ser-473) and mTOR (Ser-2448) and increased expression of microtubule-associated protein light chain 3-II, an autophagosome marker. These results suggest that the β1-AR pathway is deleterious and the β2-AR is protective in masseter muscle. These data should be helpful in developing pharmacological approaches for the treatment of skeletal muscle wasting and weakness. |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 1932-6203 |
Relation: | https://doaj.org/toc/1932-6203 |
DOI: | 10.1371/journal.pone.0215539 |
Access URL: | https://doaj.org/article/b0b9646fc0fa4266ad39eab894d11fc1 |
Accession Number: | edsdoj.b0b9646fc0fa4266ad39eab894d11fc1 |
Database: | Directory of Open Access Journals |
Full text is not displayed to guests. | Login for full access. |
ISSN: | 19326203 |
---|---|
DOI: | 10.1371/journal.pone.0215539 |
Published in: | PLoS ONE |
Language: | English |